San Martin, CA, United States of America

Gonzalo Naranjo

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gonzalo Naranjo: Innovator in Pregabalin Detection

Introduction

Gonzalo Naranjo is a notable inventor based in San Martin, CA (US). He has made significant contributions to the field of immunoassays, particularly in the detection of pregabalin. With a total of three patents to his name, Naranjo's work has the potential to impact medical diagnostics significantly.

Latest Patents

Naranjo's latest patents focus on compounds and methods for detecting pregabalin in samples suspected of containing the substance. His innovations include the development of pregabalin derivatives for producing conjugates. One of his key inventions is a pregabalin-immunogenic carrier conjugate, which can be utilized as an immunogen for preparing anti-pregabalin antibodies. Additionally, he has created a pregabalin-detectable label conjugate that can be employed in signal-producing systems for pregabalin assays.

Career Highlights

Gonzalo Naranjo is currently associated with Ark Diagnostics, Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in clinical settings, particularly in improving the accuracy of drug detection.

Collaborations

Naranjo collaborates with talented individuals such as Johnny Jose Valdez and Byung Sook Moon. Their combined expertise contributes to the innovative environment at Ark Diagnostics, Inc.

Conclusion

Gonzalo Naranjo's contributions to the field of immunoassays and his focus on pregabalin detection highlight his role as an influential inventor. His work not only advances scientific knowledge but also has practical implications for medical diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…